First antibody treatment designed against COVID-19 hits trials 02-Jun-2020 By Ben Hargreaves Eli Lilly’s potential treatment is the first coronavirus-specific mAb to enter trials and large-scale manufacturing efforts will commence immediately.
AbCellera in COVID-19 antibody discovery pact with Eli Lilly 26-May-2020 By Ben Hargreaves The two companies will partner to work on the discovery of nine antibodies, with the initial target being COVID-19-related.
